The global CT Scanners market is projected to reach US$ 11.5 billion by 2034, driven by increasing adoption of 3D imaging systems, advancements in low-dose CT scanners, and rising demand for minimally invasive procedures. North America is expected to maintain its dominant position in the market, followed by Europe and Asia Pacific.
Scientists at Stanford University have discovered that a common food dye found in Doritos, FD&C Yellow 5, can temporarily turn mouse skin transparent, allowing researchers to visualize internal organs without surgery. This breakthrough, published in the journal ‘Science’, offers exciting potential for non-invasive medical imaging and research.
Scientists have discovered a way to make the skin of living mice transparent using a common food dye called tartrazine. This breakthrough allows researchers to visualize internal organs and tissues without surgery, potentially revolutionizing medical imaging and research.
Kent Imaging, a Calgary-based company, has created an innovative handheld imaging device that utilizes light wavelengths to assess blood oxygen levels. This breakthrough technology, known as “Snapshot N-I-R,” is transforming surgical and chronic wound care practices by providing valuable insights into tissue health and wound healing rates.
GE Healthcare (GEHC) reported mixed first-quarter results on Tuesday, with revenue and earnings slightly missing estimates. The company’s total revenue declined by 1% year over year to $4.65 billion, while adjusted earnings per share came in at $0.90, missing the consensus by 1 cent. Despite the disappointing results, GE Healthcare maintained its full-year guidance and expressed optimism about the business’s growth prospects. The market reacted negatively to the earnings, sending the stock down by nearly 14% in Tuesday’s trading session. However, analysts believe that the sell-off is an overreaction and that GEHC remains an attractive investment opportunity due to its strong market position and growth potential in areas such as Alzheimer’s disease diagnostics.
Artificial intelligence (AI) and machine learning (ML) are revolutionizing healthcare by enhancing diagnostics, automating tasks, and enabling personalized medicine. This article provides insights into the transformative applications of AI and ML in healthcare and their profound impact on patient care and healthcare delivery.
The global radiopharmaceuticals market is projected to grow at a CAGR of 10.22% from 2023 to 2027, according to Technavio. This growth is primarily attributed to the increasing prevalence of neurological disorders, rising demand for early and accurate disease diagnosis, and advancements in medical imaging technologies. Radiopharmaceuticals play a vital role in the diagnosis and treatment of various diseases, including cancer, cardiovascular diseases, and neurological disorders. The market is expected to witness significant growth due to the increasing adoption of personalized medicine, the development of new radiopharmaceuticals, and the expansion of the geriatric population.
